ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 194 filers reported holding ACORDA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,000 | -62.5% | 3,713 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | -27.3% | 3,713 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $11,000 | -60.7% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $28,000 | -42.9% | 3,713 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $49,000 | -15.5% | 3,713 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $58,000 | -20.5% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $73,000 | -31.8% | 3,713 | 0.0% | 0.00% | -40.0% |
| Q2 2018 | $107,000 | +21.6% | 3,713 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $88,000 | +10.0% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $80,000 | +3.9% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $77,000 | +5.5% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $73,000 | -6.4% | 3,713 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $78,000 | -84.1% | 3,713 | -74.9% | 0.00% | -87.5% |
| Q1 2015 | $492,000 | – | 14,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |